Daxor (DXR) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for July 15, 2024, at Nasdaq Stock Exchange offices in New York.

• Shareholders will vote on electing six directors and ratifying Citrin Cooperman, LLP as the independent auditor for 2024.

• Board recommends voting for all director nominees and for auditor ratification.

• Shareholders of record as of May 17, 2024, are eligible to vote; each share equals one vote.

Voting matters and shareholder proposals

• Proposal 1: Elect six directors for one-year terms.

• Proposal 2: Ratify Citrin Cooperman, LLP as independent registered public accounting firm for 2024.

• Board recommends voting for all nominees and for auditor ratification.

• Shareholder proposals for the 2025 meeting must be received by February 1, 2025.

Board of directors and corporate governance

• Board consists of six members, four of whom are independent.

• No standing compensation or nominating committees due to controlled company status; full Board handles nominations and compensation.

• Board leadership structure includes Michael Feldschuh as Chairman; no lead independent director.

• Directors' qualifications emphasize experience in management, science, law, and finance.

• Board encourages director attendance at meetings, including via teleconference.